A microchip-based device previously used to detect circulating tumor cells (CTCs), or tumor cells in the bloodstream, can now be used to analyze genetic changes in those cells. This means the device can help determine how sensitive the cancerous tumors are to drugs called TKIs (Iressa and Tarceva). The device’s newfound ability may help doctors form better courses of treatment for lung cancer patients.
See all
